NCT03787004View on ClinicalTrials.gov

A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 14, 2017

Primary Completion Date

August 19, 2018

Study Completion Date

September 26, 2018

Conditions
Chronic PainNociceptive Pain
Interventions
DRUG

CNTX-6970

Oral dose CNTX-6970

OTHER

Placebo

Oral dose placebo

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY